Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William A Parsonage

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Emergency Medicine Australasia : EMA|November 1, 2008
More biomarkers for risk stratification of chest pain: bigger, faster, better?William A Parsonage
Trends in Pharmacological Sciences|June 7, 2005
Fundamental considerations of beta-adrenoceptor subtypes in human heart failurePeter Molenaar, William A Parsonage
Heart, Lung & Circulation|February 21, 2021
The Cardiac Society of Australia and New Zealand (CSANZ) Guidelines and Quality Standards Committee: How to use it. A guide for fellows and authorsWilliam A Parsonage, Derek P Chew
European Heart Journal|April 30, 2005
Getting to the heart of obesityWilliam A Parsonage, Dike B Ojji
British Journal of Pharmacology|January 25, 2006
Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wastingPeter Molenaar, Lu Chen, William A Parsonage
The Medical Journal of Australia|July 9, 2013
The approach to patients with possible cardiac chest painWilliam A Parsonage, Louise Cullen, John F Younger
Heart, Lung & Circulation|September 10, 2019
Tackling Disparities in Heart Care and Disease Outcomes in Women: Insights and Highlights From the Women and Heart Disease ForumClare Arnott, William A Parsonage, Gemma A Figtree
Heart, Lung & Circulation|May 22, 2012
The role of cardiac computed tomography in assessment of acute chest painWilliam A Parsonage, Louise Cullen, John F Younger, et al.
BMJ Open|June 12, 2017
The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysisPaul Jülicher, Jaimi H Greenslade, William A Parsonage, et al.
The American Journal of Cardiology|March 23, 2005
Value of B-type natriuretic peptide for identifying significantly elevated pulmonary artery wedge pressure in patients treated for established chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathyWilliam A Parsonage, Andrew J Galbraith, Gary L Koerbin, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Emergency Medicine Australasia : EMA|November 1, 2008
More biomarkers for risk stratification of chest pain: bigger, faster, better?William A Parsonage
Trends in Pharmacological Sciences|June 7, 2005
Fundamental considerations of beta-adrenoceptor subtypes in human heart failurePeter Molenaar, William A Parsonage
Heart, Lung & Circulation|February 21, 2021
The Cardiac Society of Australia and New Zealand (CSANZ) Guidelines and Quality Standards Committee: How to use it. A guide for fellows and authorsWilliam A Parsonage, Derek P Chew
European Heart Journal|April 30, 2005
Getting to the heart of obesityWilliam A Parsonage, Dike B Ojji
British Journal of Pharmacology|January 25, 2006
Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wastingPeter Molenaar, Lu Chen, William A Parsonage
The Medical Journal of Australia|July 9, 2013
The approach to patients with possible cardiac chest painWilliam A Parsonage, Louise Cullen, John F Younger
Heart, Lung & Circulation|September 10, 2019
Tackling Disparities in Heart Care and Disease Outcomes in Women: Insights and Highlights From the Women and Heart Disease ForumClare Arnott, William A Parsonage, Gemma A Figtree
Heart, Lung & Circulation|May 22, 2012
The role of cardiac computed tomography in assessment of acute chest painWilliam A Parsonage, Louise Cullen, John F Younger, et al.
BMJ Open|June 12, 2017
The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysisPaul Jülicher, Jaimi H Greenslade, William A Parsonage, et al.
The American Journal of Cardiology|March 23, 2005
Value of B-type natriuretic peptide for identifying significantly elevated pulmonary artery wedge pressure in patients treated for established chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathyWilliam A Parsonage, Andrew J Galbraith, Gary L Koerbin, et al.
Pageof 7